Logo image
Sign in
Back
The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis: Fig. 1
Journal article

The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis: Fig. 1

Clémentine Gamonet, Marina Deschamps, Sandrine Marion, Georges Herbein, Gilles Chiocchia, Isabelle Auger, Philippe Saas, Christophe Ferrand and Eric Toussirot
Rheumatology, Vol.54(9), pp.1744-1745
14/08/2015
DOI: https://doi.org/10.1093/rheumatology/kev210
PMID: 26117335

Abstract

Antigens, CD20 / genetics* Antigens, CD20 / metabolism* Case-Control Studies Drug Resistance / immunology* Female Follow-Up Studies Genetic Variation / genetics* Humans Male Middle Aged Rituximab / therapeutic use* Synovial Membrane / pathology Antirheumatic Agents / therapeutic use* Treatment Outcome Arthritis, Rheumatoid / drug therapy* Arthritis, Rheumatoid / immunology Arthritis, Rheumatoid / pathology B-Lymphocytes / metabolism B-Lymphocytes / pathology Biomarkers / metabolism Biopsy
url
Find in HALView
url
https://doi.org/10.1093/rheumatology/kev210View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image